Genesee Valley Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$1.39M Sell
17,385
-521
-3% -$43K 0.56% 35
2017
Q4
$1.45M Buy
17,906
+1,313
+8% +$105K 0.6% 34
2017
Q3
$1.29M Sell
16,593
-242
-1% -$20.1K 0.53% 38
2017
Q2
$1.49M Buy
16,835
+144
+0.9% +$12.1K 0.63% 35
2017
Q1
$1.34K Buy
16,691
+1,271
+8% +$99.3K 0.92% 26
2016
Q4
$1.1K Buy
15,420
+4,384
+40% +$344K 0.78% 34
2016
Q3
$954K Sell
11,036
-20
-0.2% -$1.74K 0.58% 46
2016
Q2
$959K Buy
11,056
+254
+2% +$20.5K 0.62% 48
2016
Q1
$810K Sell
10,802
-199
-2% -$15K 0.55% 62
2015
Q4
$846K Sell
11,001
-149
-1% -$11.2K 0.56% 56
2015
Q3
$746K Sell
11,150
-2,544
-19% -$187K 0.5% 61
2015
Q2
$1.01M Buy
13,694
+2,149
+19% +$164K 0.65% 34
2015
Q1
$900K Buy
+11,545
New +$875K 0.56% 44

Other funds holding MDT

Genesee Valley Trust's MDT Position: Q1 2018 in Review

Genesee Valley Trust reduced its Medtronic (MDT) stake by 2.9% in Q1 2018, selling an estimated $43K and leaving 17,385 shares worth $1.39M. The position accounts for 0.56% of the portfolio, ranked #35.

Genesee Valley Trust first reported a position in MDT in Q1 2015 and has held it in 13 quarters since. The position peaked at $1.49M in Q2 2017. 1,381 funds tracked by Wall St. Rank hold MDT as of Q1 2018.

  • Genesee Valley Trust held 17,385 shares of Medtronic worth $1.39M as of Q1 2018.
  • Genesee Valley Trust sold 521 Medtronic shares in Q1 2018, an estimated $43K.
  • Medtronic made up 0.56% of Genesee Valley Trust's portfolio in Q1 2018, its #35 holding.
  • Genesee Valley Trust first reported a position in Medtronic in Q1 2015 and has held it in 13 quarters since.
  • Genesee Valley Trust's Medtronic position peaked at $1.49M in Q2 2017.
  • 1,381 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.

Based on Genesee Valley Trust's 13F filing for Q1 2018, filed 3 Apr 2018.